Probiotic Yeast from Miso Ameliorates Stress-Induced Visceral Hypersensitivity by Modulating the Gut Microbiota in a Rat Model of Irritable Bowel Syndrome
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Recent studies indicate that probiotics, which have attracted attention as a treatment for irritable bowel syndrome, affect intestinal homeostasis. In this study, we investigated whether Zygosaccharomyces sapae (strain I-6), a probiotic yeast isolated from miso (a traditional Japanese fermented food), could improve irritable bowel syndrome symptoms. Methods: Male Wistar rats were exposed to water avoidance stress (WAS). The number of defecations during WAS and the visceral hypersensitivity before and after WAS were evaluated using colorectal distension. Tight junction changes were assessed by Western blotting. Some rats were fed with strain I-6 or β-glucan from strain I-6. Changes in the intestinal microbiota were analyzed. The effect of fecal microbiota transplantation after WAS was evaluated similarly. Caco-2 cells were stimulated with interleukin-1β and tight junction changes were investigated after coculture with strain I-6. Results: The increased number of stool pellets and visceral hypersensitivity induced by WAS were suppressed by administering strain I-6. The decrease in tight junction protein occludin by WAS was reversed by the administration of strain I-6. β-Glucan from strain I-6 also suppressed those changes induced by WAS. In the rat intestinal microbiota, treatment with strain I-6 altered the β-diversity and induced changes in bacterial occupancy. Upon fecal microbiota transplantation, some symptoms caused by WAS were ameliorated. Conclusions: These results suggest that traditional fermented foods such as miso in Japan are valuable sources of probiotic yeast candidates, which may be useful for preventing and treating stress-induced visceral hypersensitivity.
Abstract
Background/Aims: Recent studies indicate that probiotics, which have attracted attention as a treatment for irritable bowel syndrome, affect intestinal homeostasis. In this study, we investigated whether Zygosaccharomyces sapae (strain I-6), a probiotic yeast isolated from miso (a traditional Japanese fermented food), could improve irritable bowel syndrome symptoms. Methods: Male Wistar rats were exposed to water avoidance stress (WAS). The number of defecations during WAS and the visceral hypersensitivity before and after WAS were evaluated using colorectal distension. Tight junction changes were assessed by Western blotting. Some rats were fed with strain I-6 or β-glucan from strain I-6. Changes in the intestinal microbiota were analyzed. The effect of fecal microbiota transplantation after WAS was evaluated similarly. Caco-2 cells were stimulated with interleukin-1β and tight junction changes were investigated after coculture with strain I-6. Results: The increased number of stool pellets and visceral hypersensitivity induced by WAS were suppressed by administering strain I-6. The decrease in tight junction protein occludin by WAS was reversed by the administration of strain I-6. β-Glucan from strain I-6 also suppressed those changes induced by WAS. In the rat intestinal microbiota, treatment with strain I-6 altered the β-diversity and induced changes in bacterial occupancy. Upon fecal microbiota transplantation, some symptoms caused by WAS were ameliorated. Conclusions: These results suggest that traditional fermented foods such as miso in Japan are valuable sources of probiotic yeast candidates, which may be useful for preventing and treating stress-induced visceral hypersensitivity.
참고문헌 (46)
- Maynard CL, "Reciprocal interactions of the intestinal microbiota and immune system", Nature, 489, pp.231~241 (2012)
- Piche T, "Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome : involvement of soluble mediators", Gut, 58, pp.196~201 (2009)
- Long Y, "MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice", Neurogastroenterol Motil, 30, pp.e13348~ (2018)
- Zhou Q, "Randomised placebocontrolled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome", Gut, 68, pp.996~1002 (2019)
- Xu D, "Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats", Gastroenterology, 146, pp.484~496 (2014)
- Bhattarai Y, "Irritable bowel syndrome : a gut microbiota-related disorder?", Am J Physiol Gastrointest Liver Physiol, 312, pp.G52~G62 (2017)
- Enck P, "Irritable bowel syndrome", Nat Rev Dis Primers, 2, pp.16014~ (2016)
- Zhang L, "Stress induces more serious barrier dysfunction in follicle-associated epithelium than villus epithelium involving mast cells and protease-activated receptor-2", Sci Rep, 7, pp.4950~ (2017)
- Turner JR, "The role of molecular remodeling in differential regulation of tight junction permeability", Semin Cell Dev Biol, 36, pp.204~212 (2014)
- Fanning AS, "The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton", J Biol Chem, 273, pp.29745~29753 (1998)
- Bermudez-Brito M, "Probiotic mechanisms of action", Ann Nutr Metab, 61, pp.160~174 (2012)
- Rodiño-Janeiro BK, "A review of microbiota and irritable bowel syndrome : future in therapies", Adv Ther, 35, pp.289~310 (2018)
- Ait-Belgnaoui A, "Bifidobacterium longum and Lactobacillus helveticus synergistically suppress stress-related visceral hypersensitivity through hypothalamic-pituitary-adrenal axis modulation", J Neurogastroenterol Motil, 24, pp.138~146 (2018)
- Ait-Belgnaoui A, "Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity : a possible action through interaction with epithelial cell cytoskeleton contraction", Gut, 55, pp.1090~1094 (2006)
- Murooka Y, "Traditional healthful fermented products of Japan", J Ind Microbiol Biotechnol, 35, pp.791~798 (2008)
- Ito K, "Review of the health benefits of habitual consumption of miso soup : focus on the effects on sympathetic nerve activity, blood pressure, and heart rate", Environ Health Prev Med, 25, pp.45~ (2020)
- Okada Y, "Novel probiotic yeast from Miso promotes regulatory dendritic cell IL-10 production and attenuates DSS-induced colitis in mice", J Gastroenterol, 56, pp.829~842 (2021)
- Amoozadeh Y, "Cell confluence regulates claudin-2 expression : possible role for ZO-1 and Rac", Am J Physiol Cell Physiol, 314, pp.C366~C378 (2018)
- Kusmiati, "Cholesterol-lowering effect of beta glucan extracted from Saccharomyces cerevisiae in rats", Sci Pharm, 84, pp.153~165 (2016)
- Vannucchi MG, "Experimental models of irritable bowel syndrome and the role of the enteric neurotransmission", J Clin Med, 7, pp.4~ (2018)
- Da Silva S, "Stress disrupts intestinal mucus barrier in rats via mucin Oglycosylation shift : prevention by a probiotic treatment", Am J Physiol Gastrointest Liver Physiol, 307, pp.G420~G429 (2014)
- Bradesi S, "Repeated exposure to water avoidance stress in rats : a new model for sustained visceral hyperalgesia", Am J Physiol Gastrointest Liver Physiol, 289, pp.G42~G53 (2005)
- Musty RE, "Criterion for learned helplessness in the rat : a redefinition", Pharmacol Biochem Behav, 36, pp.739~744 (1990)
- Caporaso JG, "QIIME allows analysis of high-throughput community sequencing data", Nat Methods, 7, pp.335~336 (2010)
- Brown GD, "Dectin-1 : a signalling non-TLR pattern-recognition receptor", Nat Rev Immunol, 6, pp.33~43 (2006)
- Reid DM, "Pattern recognition : recent insights from Dectin-1", Curr Opin Immunol, 21, pp.30~37 (2009)
- Chen J, "Medicinal importance of fungal beta-(1-->3), (1-->6)-glucans", Mycol Res, 111(Pt 6), pp.635~652 (2007)
- Vannucci L, "Immunostimulatory properties and antitumor activities of glucans(review)", Int J Oncol, 43, pp.357~364 (2013)
- West C, "Effects of Saccharomyces cerevisiae or boulardii yeasts on acute stress induced intestinal dysmotility", World J Gastroenterol, 22, pp.10532~10544 (2016)
- Brun P, "Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS", PLoS One, 12, pp.e0181863~ (2017)
- Distrutti E, "Gut microbiota role in irritable bowel syndrome : new therapeutic strategies", World J Gastroenterol, 22, pp.2219~2241 (2016)
- (2020)[URL]
- Lin N, "The protective effect of trefoil factor 3 on the intestinal tight junction barrier is mediated by tolllike receptor 2 via a PI3K", Akt dependent mechanism, 2013, pp.440, 143~149
- Ikeda Y, "Dissociation of Toll-like receptor 2-mediated innate immune response to Zymosan by organic solvent-treatment without loss of Dectin-1 reactivity", Biol Pharm Bull, 31, pp.13~18 (2008)
- Dong JP, "Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice", Chin Med J(Engl), 132, pp.1951~1958 (2019)
- Lacy BE, "Review article : an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome", Aliment Pharmacol Ther, 48, pp.817~830 (2018)
- Shapiro J, "Risk of bias analysis of systematic reviews of probiotics for treatment of irritable bowel syndrome", Clin Gastroenterol Hepatol, 17, pp.784~785 (2019)
- Balsari A, "The fecal microbial population in the irritable bowel syndrome", Microbiologica, 5, pp.185~194 (1982)
- Malinen E, "Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR", Am J Gastroenterol, 100, pp.373~382 (2005)
- Chassard C, "Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome", Aliment Pharmacol Ther, 35, pp.828~838 (2012)
- Russo P, "Beta-glucans improve growth, viability and colonization of probiotic microorganisms", Int J Mol Sci, 13, pp.6026~6039 (2012)
- Lee JM, "β-glucooligosaccharides derived from barley β-glucan promote growth of lactic acid bacteria and enhance nisin Z secretion by Lactococcus lactis", LWT, 122, pp.109014~ (2020)
- Nobaek S, "Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome", Am J Gastroenterol, 95, pp.1231~1238 (2000)
- Ducrotté P, "Clinical trial : Lactobacillus plantarum 299v(DSM 9843)improves symptoms of irritable bowel syndrome", World J Gastroenterol, 18, pp.4012~4018 (2012)
- Vandeputte D, "Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates", Gut, 65, pp.57~62 (2016)
- Wang H, "Yeast β-glucan, a potential prebiotic, showed a similar probiotic activity to inulin", Food Funct, 11, pp.10386~10396 (2020)